Skip to main content
Year archive

Cipla Ltd. — 2019 filings

All 258 regulatory filings released by Cipla Ltd. (CIPLA) in 2019, sourced directly from the official regulator.

258 Filings
2019 Period
2019 filings (258)
Filing Released Lang
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-12-16 English
Please find enclosed schedule of analyst / investor meetings of the Company.
Regulatory Filings
2019-12-16 English
Press Release
Capital/Financing Update
2019-12-16 English
Please find enclosed press release dated December 16, 2019 for acquisition of trademark rights of Vysov by the Company.
Capital/Financing Update
2019-12-16 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-12-13 English
The Operations and Administrative Committee of the Company on 13th December, 2019 has allotted 2,484 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option ....
Regulatory Filings
2019-12-13 English
Press Release
Regulatory Filings
2019-12-11 English
Please find enclosed press release dated 11th December, 2019 by Avenue Therapeutics Inc., USA, associate company of Cipla Limited.
Regulatory Filings
2019-12-11 English
Updates
Regulatory Filings
2019-12-09 English
We have been intimated by our Registrar and Share Transfer Agent that their name has changed from "KARVY FINTECH PRIVATE LIMITED" to "KFIN TECHNOLOGIES PRIVATE LIMITED" w.e.f. 5th December 2019. ....
Regulatory Filings
2019-12-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2019-12-06 English
Please find enclosed schedule of analyst / investor meetings of the Company
Call Transcript
2019-12-06 English
Related Party Transactions
Interim / Quarterly Report H1 2020
2019-12-03 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions on a consolidated ....
Interim / Quarterly Report H1 2020
2019-12-03 English
Please find enclosed schedule of analyst / investor meetings of the Company
Regulatory Filings
2019-11-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet
2019-11-29 English
Acquisition
Capital/Financing Update
2019-11-27 English
Cipla Limited''s wholly owned subsidiary Cipla (EU) Limited, holding 60% stake in Cipla Pharma Lanka (Private) Limited {Cipla Pharma Lanka), Sri Lanka, has signed an agreement with CitiHealth ....
M&A Activity
2019-11-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet
2019-11-20 English
Please find enclosed the schedule of analyst / institutional investor meetings with the Company.
Fund Information / Factsheet
2019-11-20 English
News Verification
Regulatory Filings
2019-11-19 English
With reference to news appeared in www.moneycontrol.com dated November 18, 2019 quoting "Wockhardt: Cipla, Dr Reddy's Labs, Carlyle & Asian Investment Fund PAG are in the fray to acquire ....
Regulatory Filings
2019-11-18 English
We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection for both Formulations and APis at our manufacturing facility ....
Regulatory Filings
2019-11-14 English
Updates
Regulatory Filings
2019-11-14 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-11-14 English
The Operations and Administrative Committee of the Company on 13th November, 2019 has allotted 1,18,382 equity shares of Rs.2/- each pursuant to exercise of the stock options by the ....
Regulatory Filings
2019-11-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)
Major Shareholding Notification
2019-11-13 English
The copy of the transcript of the Company''s Q2 FY20 earnings conference call dated 6th November, 2019. The transcript is also available on the Company''s website i.e. www.cipla.com ....
Call Transcript
2019-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2019-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-11-07 English
Please find enclosed schedule of analyst / institutional investors meeting with the Company
Regulatory Filings
2019-11-07 English
Financial Results Updates
Interim / Quarterly Report
2019-11-06 English
Financial Result Updates
Regulatory Filings
2019-11-06 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 06th November, 2019
Regulatory Filings
2019-11-06 English
Outcome of Board Meeting
Regulatory Filings
2019-11-06 English
Updates
Interim / Quarterly Report
2019-11-06 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 06th November, 2019.
Interim / Quarterly Report H1 2020
2019-11-06 English
Please find enclosed letter dated 6th November, 2019.
Investor Presentation
2019-11-06 English
Investor Presentation
Investor Presentation
2019-11-06 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached press release dated 06th November, 2019
Interim / Quarterly Report Q2 2020
2019-11-06 English
Press Release
Interim / Quarterly Report Q2 2020
2019-11-06 English
Please find enclosed letter dated 6th November, 2019.
Interim / Quarterly Report
2019-11-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2019-11-05 English
Please find attached letter dated 5th November, 2019
Share Issue/Capital Change
2019-11-05 English
Please find enclosed Certificate from a practicing company secretary in compliance with Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2019-10-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Q2 2020
2019-10-18 English
The Company will host an Earnings conference call at 1700 hrs IST (1930 hrs SST/HKT, 1230 hrs BST, 0730 hrs US ET), during which the leadership team will discuss the financial performance ....
Earnings Release Q2 2020
2019-10-18 English
We are enclosing herewith Compliance Certificate, duly signed by the Compliance Officer of the Company and the Registrar and Share Transfer Agent, Karvy Fintech Private Limited (SEBI ....
Regulatory Filings
2019-10-17 English
Press Release
Capital/Financing Update
2019-10-17 English
Please find enclosed press release dated 17th October, 2019, regarding acquisition of a novel and patented anti-infective asset, Elores, from Venus Remedies Limited.
Capital/Financing Update
2019-10-17 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-10-17 English
The Operations and Administrative Committee of the Company on 16th October, 2019 has allotted 29,233 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option ....
Regulatory Filings
2019-10-17 English
Updates
Regulatory Filings
2019-10-15 English
In continuation to our letter dated 14th October 2019, please find enclosed notice of the Board meeting published in newspapers viz. Business Standard and Sakaal on 15th October, 2019
Regulatory Filings
2019-10-15 English
Board Meeting — Financial Results
Regulatory Filings
2019-10-14 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2019 ,inter alia, to consider and approve A meeting of the Board of Directors ....
Regulatory Filings
2019-10-14 English
Updates
Regulatory Filings
2019-09-28 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the United States Food and Drug Administration (USFDA) ....
Regulatory Filings
2019-09-28 English
Press Release
Regulatory Filings
2019-09-25 English
Press Release - Cipla announces the launch of Daptomycin for injection, 500 mg/vial, single-dose vials (for intravenous use only)
Capital/Financing Update
2019-09-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-09-25 English
Schedule of Analyst /Institutional Investor Meeting of the Company
Investor Presentation
2019-09-25 English
Updates
Regulatory Filings
2019-09-22 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that following the inspection by the United States Food ....
Regulatory Filings
2019-09-22 English
Please find enclosed schedule of analyst / institutional investor meetings of the Company
Fund Information / Factsheet
2019-09-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet
2019-09-19 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-09-16 English
The Operations and Administrative Committee of the Company on 16th September, 2019 has allotted 1,22,883 equity shares of Rs.2/- each pursuant to exercise of the stock options by the ....
Regulatory Filings
2019-09-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-09-13 English
Please find enclosed the schedule of analyst and institutional investor meetings of the Company.
Regulatory Filings
2019-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-09-03 English
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, attached herewith is the schedule of Analysts / Institutional Investor Meetings.
Regulatory Filings
2019-09-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-08-26 English
Please find enclosed the schedule of analyst / institutional investor meetings.
Investor Presentation
2019-08-26 English
Please find enclosed the schedule of analyst / institutional investor meetings of the Company
Investor Presentation
2019-08-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet
2019-08-20 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2019-08-16 English
Please find enclosed details of the Voting Results of the 83rd Annual General Meeting of the Company held on Friday, 16th August, 2019 at 3.00 P.M. (IST) in the format as prescribed under ....
Regulatory Filings
2019-08-16 English
Shareholders meeting
AGM Information
2019-08-16 English
The summary of proceedings of Annual General Meeting (the "AGM") pursuant to Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed.
Regulatory Filings
2019-08-16 English
Updates
AGM Information
2019-08-16 English
Please find enclosed copy of address made by Dr. Y.K. Hamied- Chairman at the 83rd Annnual General Meeting of the Company held on Friday, 16th August, 2019 at 3.00 p.m.at Birla Matushri ....
AGM Information
2019-08-16 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-08-15 English
Please find attached announcement dated 15th August, 2019.
Regulatory Filings
2019-08-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2019-08-13 English
We are enclosing herewith copy of the transcript of the Company''s Q1 FY 20 earnings conference call dated 7 August 2019. The transcript is also available on the Company''s website ....
Regulatory Filings
2019-08-13 English
Updates
Interim / Quarterly Report Q1 2020
2019-08-07 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 07th August, 2019.
Interim / Quarterly Report Q1 2020
2019-08-07 English
Outcome of Board Meeting
Regulatory Filings
2019-08-07 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 07th August, 2019
Regulatory Filings
2019-08-07 English
Financial Result Updates
Regulatory Filings
2019-08-07 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached press release dated 07th August, 2019.
Investor Presentation
2019-08-07 English
Investor Presentation
Investor Presentation
2019-08-07 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached press release dated 07th August, 2019
Interim / Quarterly Report Q1 2020
2019-08-07 English
Press Release
Interim / Quarterly Report Q1 2020
2019-08-07 English
Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, it is hereby informed that Cipla Limited ('the Company') has signed a definitive agreement today to acquire the minority ....
Capital/Financing Update
2019-08-07 English
Updates
Capital/Financing Update
2019-08-07 English
Financial Results Updates
Interim / Quarterly Report
2019-08-07 English
Please find attached letter dated 07th August, 2019
Regulatory Filings
2019-08-07 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group
Regulatory Filings
2019-08-06 English
ALVOTECH AND CIPLA GULF ENTER INTO A PARTNERSHIP FOR THE COMMERCIALIZATION OF KEY BIOSIMILAR IN SELECT EMERGING MARKETS.
Regulatory Filings
2019-07-29 English
Press Release
Regulatory Filings
2019-07-29 English
Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI™ (IV Plazomicin).
Regulatory Filings
2019-07-24 English
Press Release
Capital/Financing Update
2019-07-24 English
Shareholders meeting
Annual Report
2019-07-24 English
Annual Report to be read with Forward looking statement.
Regulatory Filings
2019-07-24 English
The Company will host an Earnings conference call during which the leadership team will discuss the financial performance and take questions. The details of the earnings conference call ....
Earnings Release Q1 2020
2019-07-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Q1 2020
2019-07-23 English
Updates
AGM Information
2019-07-23 English
Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the newspaper cuttings of ....
Regulatory Filings
2019-07-23 English
AGM/Book Closure
Report Publication Announcement
2019-07-23 English
"InvaGen Pharmaceuticals Inc. (Cipla''s wholly owned step down subsidiary) receives final approval for generic version of Pfizer Lyrica (Pregabalin Capsules,25mg, 50mg, 75mg, 100mg, 150mg, ....
Regulatory Filings
2019-07-22 English
Press Release
Regulatory Filings
2019-07-22 English
Updates
Notice of Dividend Amount
2019-07-20 English
The Company vide letter dated 22nd May 2019 had intimated that the Board of Directors had approved the proposal for raising funds upto Rs. 3000 crores by issue of non-convertible debentures ....
Regulatory Filings
2019-07-20 English
The Company vide letter dated 22nd May, 2019 had intimated that the Board of Directors had recommended payment of dividend of Rs. 3 per equity share (face value Rs. 2 per equity share) ....
Regulatory Filings
2019-07-20 English
Notice of the 83rd Annual General Meeting ('AGM') along with the copy of the Annual Report for the year ended 31st March, 2019
Regulatory Filings
2019-07-20 English
This is further to our letter dated 19th July 2019.The dates of inspection were inadvertently mentioned as 15th June 2019 to 19th June 2019 instead of 15th July 2019 to 19th July 2019. ....
Regulatory Filings
2019-07-20 English
Updates
Regulatory Filings
2019-07-20 English
We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection at our API manufacturing facility in Virgonangar, Bengaluru, ....
Regulatory Filings
2019-07-20 English
Updates
Regulatory Filings
2019-07-19 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-07-16 English
The Operations and Administrative Committee of the Company on 15th July, 2019 has allotted 59,580 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option ....
Regulatory Filings
2019-07-16 English
Updates
Regulatory Filings
2019-07-16 English
In continuation to our letter dated 15th July, 2019, with regard to Board Meeting Notice,please find enclosed advertisement published in newspapers viz. Business Standard and Sakal on 16th July,2019.
Regulatory Filings
2019-07-16 English
Acquisition
Capital/Financing Update
2019-07-15 English
We wish to inform you that Cipla (EU) Limited, U.K., wholly owned subsidiary of the Company has entered into a joint venture agreement with Jiangsu Acebright Pharmaceutical Co., Ltd. ('Acebright'), ..
Regulatory Filings
2019-07-15 English
Board Meeting — Financial Results
Regulatory Filings
2019-07-15 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2019 ,inter alia, to consider and approve unaudited financial results (standalone ....
Regulatory Filings
2019-07-15 English
Related Party Transactions
Interim / Quarterly Report H2 2019
2019-06-24 English
Please find enclosed disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 31st March, 2019. ....
Interim / Quarterly Report
2019-06-21 English
Resignation
Regulatory Filings
2019-06-21 English
We hereby notify that Mr. Peter Lankau, Independent Director of the Company has submitted his resignation effective 1st July, 2019 due to his other professional engagements which he is ....
Regulatory Filings
2019-06-21 English
Updates
Regulatory Filings
2019-06-17 English
Please find attached herewith copies of newspaper notice published in Business Standard (English) and Sakal (Marathi) on 15th June, 2019. The above notice is for shareholders who ....
Regulatory Filings
2019-06-17 English
Updates
Regulatory Filings
2019-06-14 English
Reference is made to the intimation given by the Company under Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on 29th May, 2019 regarding issuance ....
Regulatory Filings
2019-06-14 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-06-14 English
The Operations and Administrative Committee of the Company on 14th June, 2019 has allotted 86,346 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees ....
Regulatory Filings
2019-06-14 English
Updates
Regulatory Filings
2019-06-10 English
This is to inform you that following the inspection by the United States Food and Drug Administration (USFDA) at the Kurkumbh manufacturing facility from 11th March 2019 to 20th March 2019, ....
Regulatory Filings
2019-06-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-06-06 English
Please find enclosed the schedule of analyst / institutional investor meetings.
Investor Presentation
2019-06-06 English
Press Release
Investor Presentation
2019-06-04 English
Please find enclosed press release announced by our step down associate company i.e. Avenue Therapeutics, Inc.
Investor Presentation
2019-06-04 English
Intimation for loss of share certificates.
Major Shareholding Notification
2019-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2019-05-28 English
Earnings call transcript dated 22nd May 2019
Call Transcript
2019-05-28 English
Please find enclosed the schedule of Analyst / Institutional Investor Meetings with the Company.
Fund Information / Factsheet
2019-05-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-05-24 English
Cipla Limited has signed an agreement on 23rd May 2019, to acquire 26% stake on a fully diluted basis in AMPSolar Power Systems Private Limited.
Capital/Financing Update
2019-05-23 English
Acquisition
Capital/Financing Update
2019-05-23 English
ESOP/ESOS/ESPS
Capital/Financing Update
2019-05-22 English
Please find attached letter dated 22nd May, 2019
Regulatory Filings
2019-05-22 English
Publish Audited Results
Interim / Quarterly Report FY 2019
2019-05-22 English
Declaration for audit reports with unmodified opinion(s)
Regulatory Filings
2019-05-22 English
Please find attached Newspaper publication Results dated 22nd May, 2019.
Interim / Quarterly Report
2019-05-22 English
Investor Presentation
Investor Presentation
2019-05-22 English
Please find attached Investor Presentation dated 22nd May, 2019
Investor Presentation
2019-05-22 English
Please find attached Press Release dated 22nd May, 2019
Annual Report FY 2019
2019-05-22 English
Press Release
Annual Report FY 2019
2019-05-22 English
Please find attached letter dated 22nd May, 2019 w.r.t. recommendation of final dividend for the FY 2018-19.
Interim / Quarterly Report
2019-05-22 English
Outcome of Board Meeting
Regulatory Filings
2019-05-22 English
Please find attached letter dt. 22nd May, 2019
Regulatory Filings
2019-05-22 English
Dividend
Interim / Quarterly Report
2019-05-22 English
Please find attached letter dated 22nd May, 2019.
Interim / Quarterly Report
2019-05-22 English
Financial Result Updates
Regulatory Filings
2019-05-22 English
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period ....
Regulatory Filings
2019-05-20 English
Updates
Regulatory Filings
2019-05-17 English
We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a post-approval inspection at our Indore facility from 13th May to 17th May, 2019. The ....
Regulatory Filings
2019-05-17 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-05-17 English
The Operations and Administrative Committee of the Company on 17th May, 2019 has allotted 38,790 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees ....
Regulatory Filings
2019-05-17 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2019 ,inter alia, to consider and approve This is to inform you that the meeting ....
Regulatory Filings
2019-05-14 English
Board Meeting — Fund Raising
Regulatory Filings
2019-05-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release FY 2019
2019-05-06 English
We wish to inform you that, the Company will host an Earnings conference call at 1600 hrs IST (1830 hrs SST/HKT, 1130 hrs BST, 0630 hrs US ET), during which the leadership team will discuss ....
Earnings Release FY 2019
2019-05-06 English
In furtherance to our letter dated 6th March 2019 (copy enclosed), we hereby inform you that Chief Judge Stark of the U.S. District Court of Delaware denied Amgen, Inc.'s request for preliminary ....
Regulatory Filings
2019-05-03 English
Updates
Regulatory Filings
2019-05-03 English
Press Release
Regulatory Filings
2019-04-30 English
We are pleased to inform you that Cipla receives final approval for generic version of Gilead Sciences, Inc's Letairis® (Ambrisentan Tabs, 5mg & 10mg)
Regulatory Filings
2019-04-30 English
Acquisition
Regulatory Filings
2019-04-27 English
This is further to our letter dated 16th April 2019, we hereby notify that the Company''s wholly owned subsidiary Cipla Medpro South Africa (Pty) Limited has completed closing of transaction ....
Regulatory Filings
2019-04-27 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-26 English
Press Release
Board/Management Information
2019-04-22 English
We are pleased to inform you that Cipla has appointed Dr. Raju Mistry as President and Global Chief People Officer.
Board/Management Information
2019-04-22 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification
2019-04-18 English
The Operations and Administrative Committee of the Company on 17th April,2019 has allotted 2,023 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees ....
Regulatory Filings
2019-04-18 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-04-18 English
Updates
Regulatory Filings
2019-04-18 English
Please find enclosed herewith the copy of advertisement published in newspapers viz. Business Standard and Sakal on 18th April,2019.
Regulatory Filings
2019-04-18 English
Please find enclosed certificate from a practicing company secretary in compliance with Regulation 40(9) of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2019-04-17 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2019-04-17 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2019 ,inter alia, to consider and approve audited financial results (standalone ....
Regulatory Filings
2019-04-17 English
We wish to inform that the Company''s wholly owned subsidiary Cipla Medpro South Africa (Pty) Limited has signed an agreement on 16th April 2019, to acquire 30% stake in Brandmed (Pty) Limited.
Capital/Financing Update
2019-04-16 English
Acquisition
Capital/Financing Update
2019-04-16 English
This is further to our letter dated 1st April 2019, we hereby notify that the Company''s wholly owned subsidiary in USA i.e. Cipla Technologies LLC has signed the definitive agreement ....
Capital/Financing Update
2019-04-15 English
Updates
M&A Activity
2019-04-15 English
Please find attached letter dated 12th April, 2019.
Regulatory Filings
2019-04-12 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Regulatory Filings
2019-04-12 English
Press Release
Regulatory Filings
2019-04-12 English
Cipla launches Niveoli™, India's first extrafine ICS-LABA combination HFA inhaler.
Regulatory Filings
2019-04-12 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings
2019-04-05 English
We hereby notify that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Board of Directors on 4th April, 2019,has, ....
Regulatory Filings
2019-04-05 English
Updates
Regulatory Filings
2019-04-04 English
Please find attached letter dated 4th April 2019
Regulatory Filings
2019-04-04 English
We wish to inform that the Company''s wholly owned subsidiary in USA i.e. Cipla Technologies LLC, has signed a binding term sheet today with Pulmatrix Inc., ("Pulmatrix") for an investment ....
Capital/Financing Update
2019-04-01 English
Updates
Regulatory Filings
2019-04-01 English
Updates
Regulatory Filings
2019-03-31 English
Please find attached letter dated 31st March 2019.
Regulatory Filings
2019-03-31 English
Please find attached letter regarding the issuance of duplicate share certificates.
Major Shareholding Notification
2019-03-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet
2019-03-27 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the schedule of Analyst ....
Regulatory Filings
2019-03-27 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for MN Rajkumar Garments LLP
Major Shareholding Notification
2019-03-26 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for MN Rajkumar Garments LLP
Major Shareholding Notification
2019-03-26 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Y K Hamied
Major Shareholding Notification
2019-03-26 English
Resignation
Regulatory Filings
2019-03-25 English
Please find attached letter dated 25th March 2019
Regulatory Filings
2019-03-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-03-25 English
Please find attached letter regarding schedule of analyst/institutional investor meetings of the Company.
Investor Presentation
2019-03-25 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-03-20 English
Allotment of 2,218 equity shares under Employee Stock Option Scheme 2013 - A of the Company.
Regulatory Filings
2019-03-20 English
Please find attached letter regarding schedule of analyst / institutional investor meetings of the Company.
AGM Information
2019-03-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-03-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-03-12 English
Please find attached letter regarding schedule of analyst / institutional investor meetings of the Company.
Investor Presentation
2019-03-12 English
Updates
Regulatory Filings
2019-03-08 English
We hereby notify that the Company''s wholly owned subsidiary Goldencross Pharma Private Limited has completed the closing of Wellthy Therapeutics Private Limited ("Wellthy"), transaction ....
Major Shareholding Notification
2019-03-08 English
Please find attached letter dated 08th March 2019.
Major Shareholding Notification
2019-03-08 English
Updates
Regulatory Filings
2019-03-06 English
We would like to inform you that the Company and its subsidiary Cipla USA, Inc., (hereafter referred to as 'Cipla') announced a phased launch of generic cinacalcet hydrochloride tablets ....
Regulatory Filings
2019-03-06 English
Please find attached letter, regarding schedule of analyst/institutional investor meetings of the Company.
Fund Information / Factsheet
2019-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-02-28 English
Please find attached schedule of analyst/ institutional investor meetings of the Company.
Investor Presentation
2019-02-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-02-21 English
Please find attached letter dated 21st February 2019, regarding schedule of analyst / institutional investor meetings.
Investor Presentation
2019-02-21 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-02-20 English
Allotment of 4,576 equity shares under Employee Stock Option Scheme 2013 - A of the Company.
Regulatory Filings
2019-02-20 English
News Clarification
Regulatory Filings
2019-02-18 English
This has reference to the email dated 18th February 2019, regarding news item appearing in DNA Money titled "Mylan recalls spray made at Cipla unit". In this regard, we submit ....
Regulatory Filings
2019-02-18 English
Acquisition
Capital/Financing Update
2019-02-18 English
Please find attached our letter dated February 18, 2019.
Regulatory Filings
2019-02-18 English
Press Release
Regulatory Filings
2019-02-18 English
Please find attached our letter dated February 18, 2019.
Regulatory Filings
2019-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2019-02-11 English
Updates
Capital/Financing Update
2019-02-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-02-08 English
Press Release
Regulatory Filings
2019-02-07 English
Updates
Interim / Quarterly Report 9M 2019
2019-02-06 English
Investor Presentation
Regulatory Filings
2019-02-06 English
Press Release
Interim / Quarterly Report Q3 2019
2019-02-06 English
Financial Result Updates
Regulatory Filings
2019-02-06 English
Press Release
Regulatory Filings
2019-01-28 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-01-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-01-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-01-08 English
Updates
Regulatory Filings
2019-01-08 English
Board Meeting — Financial Results
Regulatory Filings
2019-01-07 English